Showing 1701-1710 of 19301 results for "".
Updated AGA Guidelines: Managing IBS with Diarrhea
https://reachmd.com/programs/gi-insights/updated-aga-guidelines-managing-ibs-with-diarrhea/14180/What are the newest AGA Clinical Practice Guidelines on managing IBS with diarrhea? Find out with this essential recap.SNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
https://reachmd.com/programs/diabetes-discourse/snap-food-insecurity-healthcare-spending-what-do-we-need-to-know/14208/Can programs like SNAP help reduce healthcare spending and alleviate food insecurity? Find out.Key COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
https://reachmd.com/programs/idsa-action-center/key-covid-19-considerations-highlights-from-poster-sessions-at-idweek/14526/As IDWeek 2022 kicks off, let’s take a look at some of the posters focused on COVID-19 presented at this year’s meeting.Individual Inaccuracy in Glomerular Filtration Rate Estimation
https://reachmd.com/programs/clinicians-roundtable/individual-inaccuracy-in-glomerular-filtration-rate-estimation/13954/A study on eGFR found new data between the individual-level differences and measured glomerular filtration rate. Let's explore the findings.Assessing Non-Invasive Monitoring Techniques for Liver Fibrosis
https://reachmd.com/programs/gi-insights/assessing-non-invasive-monitoring-techniques-for-liver-fibrosis/13739/Let’s explore the non-invasive techniques we can use to assess liver fibrosis in our patients.Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
https://reachmd.com/programs/project-oncology/updates-on-breast-cancer-treatment-exploring-cdk46-inhibitors-endocrine-therapy/13760/When breast cancer progresses for patients on a CDK4/6 inhibitor, should we switch to endocrine therapy?Investigating Esophageal Strictures
https://reachmd.com/programs/gi-insights/investigating-esophageal-strictures/13747/How can we improve the treatment of benign esophageal strictures?The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
https://reachmd.com/programs/project-oncology/the-emerging-role-of-immunotherapy-in-triple-negative-breast-cancer/13750/As immunotherapy begins to move into the field of triple-negative breast cancer, what do we need to know?Not the Average Investor
https://modernaesthetics.com/topics/practice-development/not-the-average-investor/35173/Why physicians need a different approach to investingA Guide for Deprescribing Proton Pump Inhibitors
https://reachmd.com/programs/gi-insights/a-guide-for-deprescribing-proton-pump-inhibitors/13683/Since the overuse of proton pump inhibitors has been associated with adverse events, here’s how we can deprescribe them in appropriate patients.